血液形成幹細胞の数は,ニッチの利用可能性によってのみ定義されるものではありません
Shoichiro Takeishi1,2, Tony Marchand3,4,5,6, Wade R Koba7
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY, USA. shoichiro.takeishi@einsteinmed.edu.
Nature
|August 27, 2025
まとめ
血液形成幹細胞 (HSC) の数は,ニッチサイズだけでなく,全身的および局所的なメカニズムによって制御されます. トロンボポエチンは,ニッチの利用可能性に関係なく,HSCの総数を制御する上で重要な役割を果たします.
科学分野:
- 血液学
- 幹細胞生物学
- 発達生物学
背景:
- 血液形成幹細胞 (HSC) は特殊なニッチに存在する.
- 古典的なモデルは,ニッチサイズが主にHSCの数を決定すると仮定しています.
- ニッチ細胞の過剰は この伝統的な見解に異議を唱えます
研究 の 目的:
- HSCの数を規制するニッチサイズの役割を調査する.
- ニッチの利用可能性がHSC集団の唯一の決定要因であるかどうかを判断する.
- HSC ホメオスタシスの全身的および局所的な調節メカニズムを解明する.
主な方法:
- HSCのニッチ可用性を操作するための股関節移植システムの開発.
- HSCの動員 欠陥のある内生ニッチから周辺部へ
- HSC移植によるパラバイオシスと骨移植を含む実験的アプローチ
主要な成果:
- ニッチ利用の拡大は,組織全体のHSC数を変化させず,組織的な規制を示唆した.
- HSCの数は 周辺に動員された時でさえ 生理学的であり 局所的な制約を示唆しています
- トロンボポエチンは,ニッチサイズに関係なく,HSCの総数を調節する重要な要因として特定されました.
結論:
- HSC番号の規制は,システムとローカル制御メカニズムの両方を含む.
- HSCの数を決定する主な要因はニッチサイズではありません.
- トロンボポエチンは,全体的な血液形成に影響を与える,HSC集団の重要な全身的調節剤である.
関連する概念動画
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Stem Cell Niche
5.3K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
5.3K
Hematopoiesis
5.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.6K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K


